Cargando…

Finding chinks in the osimertinib resistance armor

Detalles Bibliográficos
Autores principales:	Leal, Jose Luis, Solomon, Benjamin, John, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653108/ https://www.ncbi.nlm.nih.gov/pubmed/33209638 http://dx.doi.org/10.21037/tlcr-20-579

Ejemplares similares

Looking for Chinks in the Armor of Bacterial Biofilms
por: Monroe, Don
Publicado: (2007)

Commentary: The time-honored practice of tonometry disinfection – Our ultimate strength or a chink in our anti-glaucoma armor?
por: Ramesh, Prasanna Venkatesh, et al.
Publicado: (2023)

Chinks in the Armor? Filaggrin-Depleted Skin Could Increase Environmental Exposures
por: Konkel, Lindsey
Publicado: (2014)

Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses
por: Komarasamy, Thamil Vaani, et al.
Publicado: (2022)

Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses
por: Cortese, Mirko, et al.
Publicado: (2021)

Recent Advances in Non-Conventional Antimicrobial Approaches for Chronic Wound Biofilms: Have We Found the ‘Chink in the Armor’?
por: Kadam, Snehal, et al.
Publicado: (2019)

A Welcome Chink in Drug Resistance
por: Meadows, Robin
Publicado: (2013)

Medical Appointment—Prof. Armor
Publicado: (1857)

Prof. Armor—Prize Essay
Publicado: (1853)

FLAURA strikes again: efficacy of osimertinib is independent of PD-L1 expression
por: Abdayem, Pamela, et al.
Publicado: (2020)

Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent Cancer
por: Hafezi, Morteza, et al.
Publicado: (2021)

HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer
por: Yamaoka, Toshimitsu, et al.
Publicado: (2020)

Sarcopenia: Loss of mighty armor against frailty and aging
por: Sasako, Takayoshi, et al.
Publicado: (2023)

Adjuvant osimertinib for resected EGFR-mutated non-small cell lung cancer: a game-changer?
por: Patel, Shruti R., et al.
Publicado: (2023)

A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients
por: Cortellini, Alessio, et al.
Publicado: (2020)

Weapons & armor
Publicado: (1978)

Vitamin D in therapy and management: armor against COVID-19 – correspondence
por: Channabasappa, Nikhil K., et al.
Publicado: (2023)

Negligible heat strain in armored vehicle officers wearing personal body armor
por: Stewart, Ian B, et al.
Publicado: (2011)

Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation
por: Kawase, Akikazu, et al.
Publicado: (2022)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
por: Ortega-Franco, Ana, et al.
Publicado: (2022)

Armored eyes of the whale shark
por: Tomita, Taketeru, et al.
Publicado: (2020)

Beating Leishmania's iron armor
por: Williams, Ruth
Publicado: (2006)

Armored Geomembrane Cover Engineering
por: Foye, Kevin
Publicado: (2011)

The facial skeleton: Armor to the brain?
por: Patil, Satishkumar G., et al.
Publicado: (2016)

On Prof. Armor’s Prize Essay
Publicado: (1853)

Make: Props and Costume Armor
por: Thorsson, Shawn
Publicado: (2016)

Delamanid: A new armor in combating drug-resistant tuberculosis
por: Xavier, Alphienes Stanley, et al.
Publicado: (2014)

Experimental study of thermal comfort on stab resistant body armor
por: Ji, Tingchao, et al.
Publicado: (2016)

Wounding characteristics and treatment principles of ground anti-armored vehicle ammunition against armored crew
por: Li, Yue, et al.
Publicado: (2023)

Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
por: Ma, Guangzhi, et al.
Publicado: (2021)

Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma
por: Baidoun, Firas, et al.
Publicado: (2021)

The Strange Case of the Armored Scale Insect and Its Bacteriome
por: Normark, Benjamin B
Publicado: (2004)

Biomineral armor in leaf-cutter ants
por: Li, Hongjie, et al.
Publicado: (2020)

Exceptional properties of hyper-resistant armor of a hydrothermal vent crab
por: Cho, Boongho, et al.
Publicado: (2022)

Targeting the Sugary Armor of Klebsiella Species
por: Patro, L. Ponoop Prasad, et al.
Publicado: (2019)

Nanoparticles Actively Fragment Armored Droplets
por: Sicard, François, et al.
Publicado: (2019)

Functional Nanocomposites in the Development of Flexible Armor
por: Mahfuz, Hassan, et al.
Publicado: (2023)

Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients
por: Hydbring, Per
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uggb2h7pq5kdpkitd0pe95ksar